• New chemical and biological entities approved by the Therapeutic Goods Administration, January 1, 2005 to May 7, 2024 

      Lexchin, Joel; Hooimeyer, Ashleigh
      Published 2024-12-02
      This dataset includes information on drug approvals by the Australian Therapeutic Goods Administration (TGA) from 2005 to May 2024. Generic, brand name, indication, approval pathway (when applicable), and date of approval ...
      Open Access
      Dataset
    • Australian Poisoning Surveillance Initiative (APSI) Databank 

      Cairns, Rose; Buckley, Nicholas; Dzidowska, Monika; Benger, Lauren; Roberts, Darren; Wright, Nicole; Wylie, Carol; Elliott, Rohan; Greene, Shaun; Dean, Danielle; Heiner, Madeline; Armstrong, Jason; Isoardi, Katherine; Chiew, Angela; Brown, Jared; Dawson, Andrew; Merwood, Nick; Soderstrom, Jessamine
      Published 2024-11-26
      The APSI Databank is a de-identified dataset derived from calls logged by poisons specialists working at Australian Poisons Information Centres (PICs) during routine clinical operations. This includes data on calls from ...
      Dataset
    • Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions 

      Henson, Jeremy D.; Vitetta, Luis; Hall, Sean
      Published 2022
      Combination tetrahydrocannabinol (THC)/cannabidiol (CBD) medicines or CBD-only medicines are prospective treatments for chronic pain, stress, anxiety, depression, and insomnia. THC and CBD increase signaling from cannabinoid ...
      Open Access
      Article
    • Enhancing Endocannabinoid Control of Stress with Cannabidiol. 

      Henson, Jeremy D; Vitetta, Luis; Quezada, Michelle; Hall, Sean
      Published 2021
      The stress response is a well-defined physiological function activated frequently by life events. However, sometimes the stress response can be inappropriate, excessive, or prolonged; in which case, it can hinder rather ...
      Open Access
      Article
    • The intestinal microbiota and improving the efficacy of COVID-19 vaccinations 

      Chen, Jiezhong; Vitetta, Luis; Henson, Jeremy D; Hall, Sean
      Published 2021
      Most COVID-19 cases are mild or asymptomatic and recover well, suggesting that effective immune responses ensue, which successfully eliminate SARS-CoV-2 viruses. However, a small proportion of patients develop severe ...
      Open Access
      Article